SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9186347
Source:
http://linkedlifedata.com/resource/pubmed/id/9186347
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007112
,
umls-concept:C0012634
,
umls-concept:C0080103
,
umls-concept:C0220901
,
umls-concept:C0279025
,
umls-concept:C0449258
,
umls-concept:C1522609
,
umls-concept:C1554112
,
umls-concept:C1709218
pubmed:issue
1
pubmed:dateCreated
1997-7-14
pubmed:abstractText
We evaluated the prognostic impact of neuroendocrine differentiation in prostate cancer with regard to the onset of endocrine therapy failure.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9186347-9186349
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0376374
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Flutamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-5347
pubmed:author
pubmed-author:BogdanowiczJ FJF
,
pubmed-author:KrijnenJ LJL
,
pubmed-author:MulderP GPG
,
pubmed-author:SeldenrijkC ACA
,
pubmed-author:van der KwastT HTH
pubmed:issnType
Print
pubmed:volume
158
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
171-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9186347-Adenocarcinoma
,
pubmed-meshheading:9186347-Aged
,
pubmed-meshheading:9186347-Aged, 80 and over
,
pubmed-meshheading:9186347-Antineoplastic Agents, Hormonal
,
pubmed-meshheading:9186347-Cell Differentiation
,
pubmed-meshheading:9186347-Disease Progression
,
pubmed-meshheading:9186347-Disease-Free Survival
,
pubmed-meshheading:9186347-Flutamide
,
pubmed-meshheading:9186347-Follow-Up Studies
,
pubmed-meshheading:9186347-Gonadotropin-Releasing Hormone
,
pubmed-meshheading:9186347-Humans
,
pubmed-meshheading:9186347-Male
,
pubmed-meshheading:9186347-Middle Aged
,
pubmed-meshheading:9186347-Multivariate Analysis
,
pubmed-meshheading:9186347-Neurosecretory Systems
,
pubmed-meshheading:9186347-Orchiectomy
,
pubmed-meshheading:9186347-Prognosis
,
pubmed-meshheading:9186347-Proportional Hazards Models
,
pubmed-meshheading:9186347-Prostatic Neoplasms
,
pubmed-meshheading:9186347-Retrospective Studies
pubmed:year
1997
pubmed:articleTitle
The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy.
pubmed:affiliation
Department of Pathology, Erasmus University, Rotterdam, The Netherlands.
pubmed:publicationType
Journal Article